![]() |
|
|
UPRES, Lipids and Nutrition 2422, Nutrition Cellulaire et Métabolique, Université de Bourgogne, 21078 Dijon Cedex, France and * Centre Européen de Recherches et dAnalyses, 21560 Couternon France
2To whom correspondence should be addressed. E-mail: jbellev{at}u-bourgogne.fr
-Linolenic acid [GLA, 18:3(n-6)], eicosapentaenoic acid
[EPA, 20:5(n-3)] and docosahexaenoic acid [DHA, 22:6(n-3)] have
been reported to prevent cardiovascular diseases. However, they are
highly unsaturated and therefore more sensitive to oxidation damage. We
investigated the effects of a diet rich in these polyunsaturated fatty
acids (PUFA) on blood pressure, plasma and lipoprotein lipid
concentrations, total antioxidant status, lipid peroxidation and
platelet function in spontaneously hypertensive rats (SHR) and
normotensive Wistar Kyoto rats (WKY). Five-week-old SHR and WKY rats
were fed for 10 wk either a diet containing Isio 4 oil or a diet rich
in GLA, EPA and DHA (5.65, 6.39 and 4.94 g/kg dry diet, respectively).
The total antioxidant status was assayed by monitoring the rate of free
radicalinduced hemolysis. VLDL-LDL sensitivity to
copper-induced lipid peroxidation was determined as the production
of thiobarbituric acid reactive substances. After dietary PUFA
supplementation, a significant decrease in blood pressure of SHR rats
(-20 mm Hg) was observed and the total antioxidant status was
enhanced. VLDL-LDL resistance to copper-induced peroxidation
was increased in both strains. The PUFA supplementation did not change
platelet maximum aggregation in SHR rats, but it decreased the
aggregation speed. In hypertensive rats, GLA + EPA + DHA
supplementation lowers blood pressure, enhances total anti-oxidant
status and resistance to lipid peroxidation, diminishes platelet
aggregation speed and lowers plasma lipid concentrations. Thus, it
enhances protection against cardiovascular diseases. Therefore,
nutritional recommendations for cardiovascular disease prevention
should take into account the pharmacologic properties of GLA, EPA and
DHA.
KEY WORDS: hypertension polyunsaturated fatty acids antioxidant status lipoproteins spontaneously hypertensive rats
This article has been cited by other articles:
![]() |
M. M. Diaz Encarnacion, G. M. Warner, C. E. Gray, J. Cheng, H. K. H. Keryakos, K. A. Nath, and J. P. Grande Signaling pathways modulated by fish oil in salt-sensitive hypertension Am J Physiol Renal Physiol, June 1, 2008; 294(6): F1323 - F1335. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sharma, I. C. Okere, M. K. Duda, D. J. Chess, K. M. O'Shea, and W. C. Stanley Potential impact of carbohydrate and fat intake on pathological left ventricular hypertrophy Cardiovasc Res, January 15, 2007; 73(2): 257 - 268. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. P. Ander, C. Hurtado, C. S. Raposo, T. G. Maddaford, J. F. Deniset, L. V. Hryshko, G. N. Pierce, and A. Lukas Differential sensitivities of the NCX1.1 and NCX1.3 isoforms of the Na+-Ca2+ exchanger to {alpha}-linolenic acid Cardiovasc Res, January 15, 2007; 73(2): 395 - 403. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. A. Gudbrandsen, M. Hultstrom, S. Leh, L. Monica Bivol, O. Vagnes, R. K. Berge, and B. M. Iversen Prevention of Hypertension and Organ Damage in 2-Kidney, 1-Clip Rats by Tetradecylthioacetic Acid Hypertension, September 1, 2006; 48(3): 460 - 466. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Iraz, H. Erdogan, B. Ozyurt, F. Ozugurlu, S. Ozgocmen, and E. Fadillioglu Omega-3 Essential Fatty Acid Supplementation and Erythrocyte Oxidant/Antioxidant Status in Rats Ann. Clin. Lab. Sci., April 1, 2005; 35(2): 169 - 173. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Mies, V. Shlyonsky, A. Goolaerts, and S. Sariban-Sohraby Modulation of epithelial Na+ channel activity by long-chain n-3 fatty acids Am J Physiol Renal Physiol, October 1, 2004; 287(4): F850 - F855. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-H. Wang, T.-M. Hung, J. Wei, and A.-N. Chiang Fish oil increases antioxidant enzyme activities in macrophages and reduces atherosclerotic lesions in apoE-knockout mice Cardiovasc Res, January 1, 2004; 61(1): 169 - 176. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. V. Yuan and D. D. Kitts Dietary (n-3) Fat and Cholesterol Alter Tissue Antioxidant Enzymes and Susceptibility to Oxidation in SHR and WKY Rats J. Nutr., March 1, 2003; 133(3): 679 - 688. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Yahia, S. Madani, E. Prost, J. Prost, M. Bouchenak, and J. Belleville Tissue Antioxidant Status Differs in Spontaneously Hypertensive Rats Fed Fish Protein or Casein J. Nutr., February 1, 2003; 133(2): 479 - 482. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Ye, D. Zhang, C. Oltman, K. Dellsperger, H.-C. Lee, and M. VanRollins Cytochrome P-450 Epoxygenase Metabolites of Docosahexaenoate Potently Dilate Coronary Arterioles by Activating Large-Conductance Calcium-Activated Potassium Channels J. Pharmacol. Exp. Ther., November 1, 2002; 303(2): 768 - 776. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Triboulot, A. Hichami, A. Denys, and N. A. Khan Dietary (n-3) Polyunsaturated Fatty Acids Exert Antihypertensive Effects by Modulating Calcium Signaling in T Cells of Rats J. Nutr., September 1, 2001; 131(9): 2364 - 2369. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. E. Hardman, C. P. R. Avula, G. Fernandes, and I. L. Cameron Three Percent Dietary Fish Oil Concentrate Increased Efficacy of Doxorubicin Against MDA-MB 231 Breast Cancer Xenografts Clin. Cancer Res., July 1, 2001; 7(7): 2041 - 2049. [Abstract] [Full Text] [PDF] |
||||